Edward Hogan to Galactosylceramides
This is a "connection" page, showing publications Edward Hogan has written about Galactosylceramides.
Connection Strength
0.957
-
Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid. J Lipid Res. 2010 Jun; 51(6):1394-406.
Score: 0.333
-
T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired. J Neurol Sci. 2008 Dec 15; 275(1-2):22-8.
Score: 0.300
-
Invariant natural killer T cells and their ligands: focus on multiple sclerosis. Immunology. 2015 Aug; 145(4):468-75.
Score: 0.121
-
Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis. J Neuroimmunol. 2013 Jun 15; 259(1-2):1-7.
Score: 0.103
-
Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li+ adducts. J Mass Spectrom. 2007 May; 42(5):598-620.
Score: 0.069
-
Regulation of the calcium-activated neutral proteinase (CANP) of bovine brain by myelin lipids. Biochim Biophys Acta. 1990 Apr 19; 1038(2):195-8.
Score: 0.021
-
Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5768-72.
Score: 0.009